US Patent 9522923 Selective BACE1 inhibitors
Patent 9522923 was granted and assigned to Eli Lilly and Company on December, 2016 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9522923 Selective BACE1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.